x
Filter:
Filters applied
- ACMG Statements and Guidelines
- Rao, Kathleen WRemove Rao, Kathleen W filter
- Wolff, Daynna JRemove Wolff, Daynna J filter
- South, Sarah TRemove South, Sarah T filter
ACMG Statements and Guidelines
These online statements and guidelines are definitive and may be cited using the digital object identifier (DOI). These recommendations are designed primarily as an educational resource for medical geneticists and other healthcare providers to help them provide quality medical genetics services; they should not be considered inclusive of all proper procedures and tests or exclusive of other procedures and tests that are reasonably directed to obtaining the same results. Please refer to the leading disclaimer in each document for more information.
1 Results
- ACMG Policy Statement and GuidelinesOpen Archive
American College of Medical Genetics recommendations for the design and performance expectations for clinical genomic copy number microarrays intended for use in the postnatal setting for detection of constitutional abnormalities
Genetics in MedicineVol. 13Issue 7p676–679Published in issue: July, 2011- Hutton M. Kearney
- Sarah T. South
- Daynna J. Wolff
- Allen Lamb
- Ada Hamosh
- Kathleen W. Rao
- and others
Cited in Scopus: 80Genomic copy number microarrays have significantly increased the diagnostic yield over a karyotype for clinically significant imbalances in individuals with developmental delay, intellectual disability, multiple congenital anomalies, and autism, and they are now accepted as a first tier diagnostic test for these indications. As it is not feasible to validate microarray technology that targets the entire genome in the same manner as an assay that targets a specific gene or syndromic region, a new paradigm of validation and regulation is needed to regulate this important diagnostic technology.
